Indian vaccine makers decry US use of wartime powers to protect supplies

Pharmaceutical chiefs say world production is threatened by US Defense Production Act

15 March 2021 - 19:55 By Stephanie Findlay and Donato Paolo Mancini

Two of India’s top vaccine manufacturers making AstraZeneca and Johnson & Johnson shots have warned that the world’s vaccine production is being threatened by America’s pandemic export controls.

Mahima Datla, CEO of pharmaceutical company Biological E, said US suppliers claim they may not be able to fulfil orders to global clients because of Washington’s use of the Defense Production Act (DPA)...

This article is reserved for Sunday Times subscribers.

A subscription gives you full digital access to all Sunday Times content.

Already subscribed? Simply sign in below.

Registered on the BusinessLIVE, Business Day or Financial Mail websites? Sign in with the same details.

Questions or problems? Email or call 0860 52 52 00.